P3-139: Evaluation of safety and efficacy of Erlotinib (Tarceva) as monotherapy in a series of Chinese patients with advanced non–small–cell lung cancer: preliminary experience from an expanded access programme
2007 ◽
Vol 2
(8)
◽
pp. S738-S739
Keyword(s):
2013 ◽
Vol 23
(3)
◽
pp. 370-379
◽
2018 ◽
Vol 100
◽
pp. 126-134
◽
2003 ◽
Vol 89
(S2)
◽
pp. S19-S23
◽
2003 ◽
Vol 1
(5)
◽
pp. S240
Keyword(s):
Keyword(s):